Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$4.1B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in developing innovative solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a critical indicator of the company's profitability and financial health.

$-0.00

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in developing innovative solutions for cardiac monitoring. With a market cap of $4 billion, it plays a significant role in the health care equipment sector, particularly as demand for remote monitoring solutions continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1-2026, iRhythm reported an EPS of $-0.35, outperforming expectations by nearly 38%. The stock reacted positively, gaining nearly 7% the following day.

Management Promises & Guidance

Focus on expanding market share in cardiac monitoring.
Commitment to improving product offerings and technology.
Plans to enhance customer support and service.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about iRhythm's upcoming earnings, expecting a break-even EPS and stable revenue figures.

Bull Case

If iRhythm can show a strong revenue increase and improved margins, it could signal a turnaround in profitability, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows continued losses, it may raise concerns about its growth strategy and market position.

Key Metrics to Watch

EPS

$-0.00

Earnings per share is a critical indicator of the company's profitability and financial health.

Revenue

$219M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will iRhythm achieve revenue of at least $219M?

Meeting or exceeding this revenue target will be crucial to demonstrate demand for their products and overall business health.

What is the outlook for EPS improvement in the coming quarters?

Investors will be keen to hear about any plans or strategies that could lead to a path toward profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate iRhythm's potential for revenue growth driven by new product launches and increased market penetration.

Supporting Evidence

The company has consistently surprised on EPS in recent quarters, suggesting stronger underlying performance.

Options pricing indicates higher volatility, which could reflect investor anticipation of positive news.

Management's focus on innovation may lead to unexpected revenue streams.

Key Risk

If revenue growth exceeds $219M, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against ongoing challenges in profitability and growth.

Bull Confirmed If

Achieving revenue growth above $219M and a path to profitability will confirm the bull case.

Bear Confirmed If

Falling short of revenue expectations or continued losses will support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a move of about 3.3%, indicating some uncertainty around the earnings report.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could rise by about 1.17%, confirming a positive outlook.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await clearer guidance from management.

Miss

If the company misses expectations, the stock could see little change, as history shows a negligible average move in such cases.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on sales.
2Any commentary on customer acquisition and retention strategies.
3Insights into market trends in cardiac monitoring.
4Management's outlook on profitability and cost management.
5Details on competitive positioning and market share.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in developing innovative solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a critical indicator of the company's profitability and financial health.

$-0.00

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1-2026, iRhythm reported an EPS of $-0.35, outperforming expectations by nearly 38%. The stock reacted positively, gaining nearly 7% the following day.

Management Promises & Guidance

Focus on expanding market share in cardiac monitoring.
Commitment to improving product offerings and technology.
Plans to enhance customer support and service.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about iRhythm's upcoming earnings, expecting a break-even EPS and stable revenue figures.

Bull Case

If iRhythm can show a strong revenue increase and improved margins, it could signal a turnaround in profitability, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows continued losses, it may raise concerns about its growth strategy and market position.

Key Metrics to Watch

EPS

$-0.00

Earnings per share is a critical indicator of the company's profitability and financial health.

Revenue

$219M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will iRhythm achieve revenue of at least $219M?

Meeting or exceeding this revenue target will be crucial to demonstrate demand for their products and overall business health.

What is the outlook for EPS improvement in the coming quarters?

Investors will be keen to hear about any plans or strategies that could lead to a path toward profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate iRhythm's potential for revenue growth driven by new product launches and increased market penetration.

Supporting Evidence

The company has consistently surprised on EPS in recent quarters, suggesting stronger underlying performance.

Options pricing indicates higher volatility, which could reflect investor anticipation of positive news.

Management's focus on innovation may lead to unexpected revenue streams.

Key Risk

If revenue growth exceeds $219M, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against ongoing challenges in profitability and growth.

Bull Confirmed If

Achieving revenue growth above $219M and a path to profitability will confirm the bull case.

Bear Confirmed If

Falling short of revenue expectations or continued losses will support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a move of about 3.3%, indicating some uncertainty around the earnings report.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could rise by about 1.17%, confirming a positive outlook.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await clearer guidance from management.

Miss

If the company misses expectations, the stock could see little change, as history shows a negligible average move in such cases.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on sales.
2Any commentary on customer acquisition and retention strategies.
3Insights into market trends in cardiac monitoring.
4Management's outlook on profitability and cost management.
5Details on competitive positioning and market share.